Wonderful Wizard

BioCryst Pharmaceuticals: A Winning Investment For The Long Term

The biotechnology industry has always appealed to investors looking for the next home run investment. One niche within that industry that appears poised to soar deals with small molecule drugs used to treat diseases. With billions of dollars being poured into this space each year, the stakes are high but so are the rewards. One company that appears on the verge of appreciating significantly is BioCryst Pharmaceuticals (NASDAQ:BCRX). Below are several reasons why investors should consider adding a position soon.

Company Background

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and inflammatory diseases. BioCryst uses revolutionary drug design, which incorporates multiple scientific disciplines including biology, crystallography, medicinal chemistry and computer...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details